AVITITM System now available for our customers in Iraq, Jordan, Lebanon and Libya

We are happy to share some exciting news with you. Our company has recently signed a distributor agreement with Element Biosciences to make its AVITI™ System available to more customers in Iraq, Jordan, Lebanon and Libya.
The AVITI™System is an advanced DNA sequencing platform that is changing the way genomics research is done. It is in high demand around the world, and this partnership with Element Biosciences allows us to bring it to our customers.
Labs around the world have shown great interest in the AVITI™ System because it offers high-quality, affordable, and easy-to-use genomics tools that accelerate discovery.
We are enthusiastic about making the AVITI™ System more accessible, and we hope that this news is as exciting for you as it is for us. If you have any questions or need more information, please feel free to reach out.

About Element Biosciences, Inc.

Element Biosciences is a pioneering life science company developing innovative technologies that empower the scientific community with more freedom and flexibility to accelerate their scientific discoveries. By reinventing every fundamental element of the assay system, we’ve created disruptive DNA sequencing and multiomics tools, including our family of AVITI™ systems. The AVITI benchtop instrument uses proprietary technology to deliver high-quality sequencing at low run costs, accessible for any scale of research operation.  Leveraging our revolutionary technology, we are adding to these capabilities, improving standard workflows, and providing multiomic readouts. Together, these innovations drive impactful discoveries that benefit humanity.

We are happy to announce our collaboration with Poietis, a company with headquarters in Bordeaux, France. Together with Poietis our mission is to provide solutions leveraging a proprietary, innovative Next-Generation Bioprinting platform and bring Tissue Engineering therapies to patients.
Poietis is a spin-off from INSERM and University of Bordeaux where Laser-Assisted Bioprinting Technology was initially developed. On the basis of its expertise in high resolution Laser-Assisted Bioprinting (LAB), Poietis has developed the Next-Generation Bioprinting (NGB) platform.

www.cytivalifesciences.com

Collaboration with CalibreScientific

We are happy to announce our collaboration with Calibre Scientific, a company with headquarters in Los Angeles, California, representing a diverse portfolio of niche life sciences companies in the fields cell & molecular biology, proteomics, applied science & diagnostics.

ViennaLab releasing the first series of multiplex (mpx) RealFast™ Assays

The ViennaLab multiplex RealFast™ Assays allow to genotype two loci simultaneously and thus save costs and sample material.

Gyros Protein Technologies introduces Gyrolab xPand to improve immunoassay workflow, flexibility and speed in biotherapeutic discovery, development and production

Gyros Protein Technologies introduces a multi-species kit for pharmacokinetic studies

New kit for early-stage biotherapeutic development, optimized for use in Gyrolab™ systems

Uppsala, Sweden, 05 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new kit for early-stage biotherapeutic pharmacokinetic (PK) studies.